Severe combined immunodeficiency (SCID) is a rare group of disorders in which immune responses are compromised by defects in the development and function of T cells. Additionally, in some forms of SCID, B and/or NK cells may also be defective (Fischer, 2000). SCID affects ...Learn More

As one of the commonest contributors to human death, cancer has always been a key research area for scientists from all over the world. In a recently published Perspective in Nature Reviews Clinical Oncology, researchers from the International Agency for Research on Cancer predict ...Learn More

Nanotechnology has shown an important potential in the immunotherapeutic field, as the modulation of a variety of immune processes can be achieved both in vitro and in vivo. Nanotechnology can be used to promote the immune activation or to induce tolerance depending on the ...Learn More

Despite its potential usefulness in completely eliminating tumor cells, cancer immunotherapy is deployed to confront intact primary or metastatic disease. It will be easier for the immune system to clear a small number of residual cancer cells, once the immunosuppressive tumor ...Learn More

This animation created by Nature Reviews Cancer and Nature Reviews Immunology illustrates how tumour cells are sensed and destroyed by cells of the immune system and how tumours can evolve to evade immune-mediated elimination. Scientists are developing new immunotherapies that ...Learn More